More importantly, no matter which group TGIF1 is in, it shows that the high expression of TGIF1 is a risk to the prognosis of glioma patients according to the molecular subtypes of gliomas (HR >1) (Figures S4G–K and S5G–K). The gene discussed is TGIF1; the disease is central nervous system cancer.